Literature DB >> 14513275

[Tumors of the adrenal medulla and the paraganglia].

G Klöppel1.   

Abstract

The sympathetic and parasympathetic paraganglia are the site of pheochromocytomas and paragangliomas. The adrenal pheochromocytoma and the abdominal paraganglioma derive from the sympathetic nervous system. The parasympathetic paragangliomas are predominantly localized in the head and neck region. Most pheochromocytomas are hormonally active and benign. The abdominal paragangliomas usually correspond to adrenal pheochromocytomas, but are more commonly malignant. The parasympathetic paragangliomas are usually benign, hormonally inactive and are most commonly located in the bifurcation of the carotid artery.

Entities:  

Mesh:

Year:  2003        PMID: 14513275     DOI: 10.1007/s00292-003-0635-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  16 in total

Review 1.  [How to differentiate sporadic and hereditary pheochromocytoma?].

Authors:  E Modigliani
Journal:  Ann Pathol       Date:  1999-12       Impact factor: 0.407

2.  Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas.

Authors:  A M Moreno; L Castilla-Guerra; M C Martínez-Torres; F Torres-Olivera; E Fernández; H Galera-Davidson
Journal:  Neuropeptides       Date:  1999-04       Impact factor: 3.286

Review 3.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 4.  Differential diagnosis of pheochromocytomas and paragangliomas.

Authors:  A M McNichol
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

5.  Immunocytochemistry of paragangliomas--value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis.

Authors:  E Achilles; B C Padberg; K Holl; G Klöppel; S Schröder
Journal:  Histopathology       Date:  1991-05       Impact factor: 5.087

6.  Immunohistochemical detection of neuroblastomatous foci in composite adrenal pheochromocytoma-neuroblastoma.

Authors:  D W Franquemont; S E Mills; E E Lack
Journal:  Am J Clin Pathol       Date:  1994-08       Impact factor: 2.493

7.  Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Authors:  Christian A Koch; David Mauro; McClellan M Walther; W Marston Linehan; Alexander O Vortmeyer; Ronald Jaffe; Karel Pacak; George P Chrousos; Zhengping Zhuang; Irina A Lubensky
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

8.  Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia.

Authors:  L M DeAngelis; M B Kelleher; K D Post; M R Fetell
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

9.  Adrenocorticotropic hormone-secreting pheochromocytomas: the exception to the rule.

Authors:  H Chen; J L Doppman; G P Chrousos; J A Norton; L K Nieman; R Udelsman
Journal:  Surgery       Date:  1995-12       Impact factor: 3.982

10.  Cyclic Cushing's syndrome due to ectopic ACTH secretion by an adrenal pheochromocytoma.

Authors:  M Terzolo; A Alì; A Pia; E Bollito; G Reimondo; P Paccotti; R Scardapane; A Angeli
Journal:  J Endocrinol Invest       Date:  1994-12       Impact factor: 4.256

View more
  3 in total

1.  [Virilizing adrenal ganglioneuroma : A rare differential diagnosis in testosterone secreting adrenal tumours].

Authors:  N T Gaisa; G Klöppel; B Brehmer; J Neulen; P Stephan; R Knüchel; A Donner
Journal:  Pathologe       Date:  2009-09       Impact factor: 1.011

Review 2.  Contemporary management of paragangliomas of the head and neck.

Authors:  Eoin F Cleere; Julie Martin-Grace; Adrien Gendre; Mark Sherlock; James P O'Neill
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-26

3.  Carotid Body Paraganglioma.

Authors:  Rashmi Maruti Hosalkar; Jayesh S Khivasara; Niharika Swain
Journal:  Ann Maxillofac Surg       Date:  2019 Jul-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.